Strategy to limit multidrug-resistant <i>Acinetobacter baumannii</i> transmission in a cohort coronavirus disease 2019 (COVID-19) critical care unit.

Apisarnthanarak, Anucha; Weber, David J

Strategy to limit multidrug-resistant Acinetobacter baumannii transmission in a cohort coronavirus disease 2019 (COVID-19) critical care unit.

Apisarnthanarak, Anucha; Weber, David J.

Apisarnthanarak A; Division of Infectious Diseases, Thammasat University Hospital, Pathum Thani, Thailand.
Weber DJ; Gillings School of Global Public Health, Chapel Hill, North Carolina, United States.

Infect Control Hosp Epidemiol ; 43(10): 1517-1518, 2022 10.

Article in English | MEDLINE | ID: covidwho-1751584

Subject(s)

Acinetobacter Infections; Acinetobacter baumannii; COVID-19; Cross Infection; Humans; Acinetobacter Infections/drug therapy; Acinetobacter Infections/epidemiology; Intensive Care Units; Critical Care; Drug Resistance, Multiple, Bacterial; Anti-Bacterial Agents/therapeutic use; Anti-Bacterial Agents/pharmacology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Acinetobacter Infections / Cross Infection / Acinetobacter baumannii / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Infect Control Hosp Epidemiol Journal subject: Communicable Diseases / Nursing / Epidemiology / Hospitals Year: 2022 Document Type: Article Affiliation country: Ice.2021.289

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google